BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36099584)

  • 1. Aptamer-Gold Nanocage Composite for Photoactivated Immunotherapy.
    Song W; Hu JJ; Song SJ; Xu Y; Yang H; Yang F; Zhou Y; Yu T; Qiu WX
    ACS Appl Mater Interfaces; 2022 Sep; 14(38):42931-42939. PubMed ID: 36099584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photothermally sensitive gold nanocage augments the antitumor efficiency of immune checkpoint blockade in immune "cold" tumors.
    Xiao G; Zhao Y; Wang X; Zeng C; Luo F; Jing J
    Front Immunol; 2023; 14():1279221. PubMed ID: 37942337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamer-Conjugated Au Nanocage/SiO
    Wen S; Miao X; Fan GC; Xu T; Jiang LP; Wu P; Cai C; Zhu JJ
    ACS Sens; 2019 Feb; 4(2):301-308. PubMed ID: 30624040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel nanotherapeutics for cancer immunotherapy by CTLA-4 aptamer-functionalized albumin nanoparticle loaded with antihistamine.
    Yao F; An Y; Lai X; Li X; Yu Z; Yang XD
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7515-7527. PubMed ID: 36966395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photothermal therapeutic response of cancer cells to aptamer-gold nanoparticle-hybridized graphene oxide under NIR illumination.
    Yang L; Tseng YT; Suo G; Chen L; Yu J; Chiu WJ; Huang CC; Lin CH
    ACS Appl Mater Interfaces; 2015 Mar; 7(9):5097-106. PubMed ID: 25705789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing anti-PD-1 Immunotherapy by Nanomicelles Self-Assembled from Multivalent Aptamer Drug Conjugates.
    Geng Z; Wang L; Liu K; Liu J; Tan W
    Angew Chem Int Ed Engl; 2021 Jul; 60(28):15459-15465. PubMed ID: 33904236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual targeting luminescent gold nanoclusters for tumor imaging and deep tissue therapy.
    Chen D; Li B; Cai S; Wang P; Peng S; Sheng Y; He Y; Gu Y; Chen H
    Biomaterials; 2016 Sep; 100():1-16. PubMed ID: 27236844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics.
    Han X; Li H; Zhou D; Chen Z; Gu Z
    Acc Chem Res; 2020 Nov; 53(11):2521-2533. PubMed ID: 33073988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cas9-edited immune checkpoint blockade PD-1 DNA polyaptamer hydrogel for cancer immunotherapy.
    Lee J; Le QV; Yang G; Oh YK
    Biomaterials; 2019 Oct; 218():119359. PubMed ID: 31349094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer immunotherapy by immune checkpoint blockade and its advanced application using bio-nanomaterials.
    Yadav D; Kwak M; Chauhan PS; Puranik N; Lee PCW; Jin JO
    Semin Cancer Biol; 2022 Nov; 86(Pt 2):909-922. PubMed ID: 35181474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA aptamer functionalized gold nanostructures for molecular recognition and photothermal inactivation of methicillin-Resistant Staphylococcus aureus.
    Ocsoy I; Yusufbeyoglu S; Yılmaz V; McLamore ES; Ildız N; Ülgen A
    Colloids Surf B Biointerfaces; 2017 Nov; 159():16-22. PubMed ID: 28778062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamer-Based Logic Computing Reaction on Living Cells to Enable Non-Antibody Immune Checkpoint Blockade Therapy.
    Yang Y; Xu J; Sun Y; Mo L; Liu B; Pan X; Liu Z; Tan W
    J Am Chem Soc; 2021 Jun; 143(22):8391-8401. PubMed ID: 34029474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-PD-L1 DNA aptamer antagonizes the interaction of PD-1/PD-L1 with antitumor effect.
    Gao T; Mao Z; Li W; Pei R
    J Mater Chem B; 2021 Jan; 9(3):746-756. PubMed ID: 33319876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of PD-1 Blockade Efficacy and Elimination of Immune-Related Gastrointestinal Adverse Effect by mTOR Inhibitor.
    Bai X; Wang X; Ma G; Song J; Liu X; Wu X; Zhao Y; Liu X; Liu Z; Zhang W; Zhao X; Zheng Z; Jing J; Shi H
    Front Immunol; 2021; 12():793831. PubMed ID: 34987517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
    Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
    J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assembly and in vitro assessment of a powerful combination: aptamer-modified exosomes combined with gold nanorods for effective photothermal therapy.
    Zheng L; Zhang B; Chu H; Cheng P; Li H; Huang K; He X; Xu W
    Nanotechnology; 2020 Nov; 31(48):485101. PubMed ID: 32931460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination immunotherapy strategies for glioblastoma.
    Chan HY; Choi J; Jackson C; Lim M
    J Neurooncol; 2021 Feb; 151(3):375-391. PubMed ID: 33611705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer nanocage platforms for combined immunotherapy designed to harness immune checkpoints and deliver anticancer drugs.
    Jeon IS; Yoo JD; Gurung S; Kim M; Lee C; Park EJ; Park RW; Lee B; Kim S
    Biomaterials; 2021 Mar; 270():120685. PubMed ID: 33524811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gold Nanocage-Based Photothermal Ablation Facilitates In Situ Vaccination for Melanoma Therapy.
    Zhang M; Chen Y; Li D; He Z; Wang H; Wu A; Fei W; Zheng C; Liu E; Huang Y
    ACS Appl Mater Interfaces; 2022 Aug; 14(34):38550-38561. PubMed ID: 35982542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Click Reaction-Assisted Peptide Immune Checkpoint Blockade for Solid Tumor Treatment.
    Xiao WY; Wang Y; An HW; Hou D; Mamuti M; Wang MD; Wang J; Xu W; Hu L; Wang H
    ACS Appl Mater Interfaces; 2020 Sep; 12(36):40042-40051. PubMed ID: 32805827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.